This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DUFAU, M. L. Articles by CATT, K. J. Search for Related Content PubMed PubMed Citation Articles by DUFAU, M. L. Articles by CATT, K. J.

In Vitro Bioassay of LH in Human Serum: The Rat Interstitial Cell Testosterone (RICT) Assay

Section on Hormonal Regulation, Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health Bethesda, Maryland 20014

A sensitive bioassay for serum LH and hCG has been developed by utilization of the testosterone response of collagenase-dispersed rat Leydig cells to gonadotropic stimulation in vitro. Testosterone production by dispersed interstitial cells is stimulated by human, ovine, bovine, porcine, rat and rabbit LH, and by hCG and pregnant mare serum gonadotropin. The rat testis interstitial cell assay gives parallel dose-response curves for all steroidogenic gonadotropins tested, and thus permits cross-species comparison of the intrinsic biological activities of native and modified gonadotropins. The sensitivity of the rat interstitial cell bioassay is equal to or higher than that of radioimmunoassay, with detection limits of 50 µU for hMG and 20 µU for hCG. The optimum conditions for bioassay of serum gonadotropins were provided by incubation of dispersed interstitial cells in the presence of 1-methyl 3-isobutyl xanthine with the addition of gonadotropin-free serum or 5% BSA to ensure a constant proportion of serum protein in all assay samples and standards. Assays performed under these conditions gave parallel dose-response curves and identical maximum responses to both standards and serum samples containing endogenous LH or hCG. All responses to human gonadotropin standards and serum samples in the bioassay were abolished by incubation in the presence of antisera to LH or hCG.

This sensitive and specific method permits bioassay of basal levels of LH in male and female serum, and of tlie higher gonadotropin levels in postmenopausal and pregnant subjects after appropriate dilution of the serum samples. For normal men and women, serum samples of 25–100 fA are employed, while volumes of 1–20 µl are adequate for assay of LH in postmenopausal or hypogonadal subjects. Serum LH values in hypopituitary and oral contraceptive-treated subjects were usually undetectable, while LH levels in normal subjects were always measurable with good precision. The within-assay coefficient of variation for measurement of a normal male plasma pool (30 mU/inl) was ±10%, and the between-assay variation was ±15%. The precision of the assay (A) was 0.035 ± 0.015 (n = 72). In 42 normal females, the bio:immuno (B:I) ratio for serum LH was 1.20 ± 0.40 (SD), and no consistent change in ratio was observed throughout the menstrual cycle. By contrast, significantly higher B:I ratios were observed in normal males (2.5 ± 0.4), postmenopausal females (2.6 ± 0.6) and patients with Turner's syndrome (2.6 ± 0.6). These findings suggest that the LH circulating in normal female plasma is similar in biological and immunological activity to hMG, whereas the LH present in normal male plasma and in states of increased gonadotropin secretion has a relatively higher biological activity. The rat interstitial cell bioassay provides for the first time a practical and precise assay for measurement of the biologically active LH levels in serum of normal human subjects.

Received September 30, 1975.

This article has been cited by other articles:

				S. Birken, P. Berger, J.-M. Bidart, M. Weber, A. Bristow, R. Norman, C. Sturgeon, and U.-H. Stenman Preparation and Characterization of New WHO Reference Reagents for Human Chorionic Gonadotropin and Metabolites Clin. Chem., January 1, 2003; 49(1): 144 - 154. [Abstract] [Full Text] [PDF]

				M. Bergendah and J. D. Veldhuis Is there a physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: III. Luteinizing hormone heterogeneity: a medical physiologist's perspective Hum. Reprod., June 1, 2001; 16(6): 1058 - 1064. [Abstract] [Full Text] [PDF]

				A. Ulloa-Aguirre, C. Timossi, and J.P. Mendez Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: I. Gondatrophins are synthesized and released in multiple molecular forms. A matter of fact Hum. Reprod., April 1, 2001; 16(4): 599 - 604. [Abstract] [Full Text] [PDF]

				M. Nagamani, C. Osuampke, and M. E. Kelver Increased Bioactive Luteinizing Hormone Levels and Bio/Immuno Ratio in Women with Hyperthecosis of the Ovaries: Possible Role of Hyperinsulinemia J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1685 - 1689. [Abstract] [Full Text]

				S. A. Roberts, T. M. Nett, H. A. Hartman, T. E. Adams, and R. E. Stoll SDZ 200-110 Induces Leydig Cell Tumors By Increasing Gonadotropins in Rats International Journal of Toxicology, May 1, 1989; 8(3): 487 - 505. [Abstract] [PDF]

				G. B. CUTLER Jr., A. R. HOFFMAN, R. S. SWERDLOFF, R. J. SANTEN, D. R. MELDRUM, and F. COMITE Therapeutic Applications of Luteinizing-Hormone-Releasing Hormone and Its Analogs Ann Intern Med, May 1, 1985; 102(5): 643 - 657. [Abstract] [PDF]